Generate a tailored SOP for Dr. Becky Carlyle. Improve your application with a focused, well-structured draft.
Becky Carlyle received her PhD from the University of Edinburgh in 2010, focusing on the interactions between mental illness risk gene, Disrupted Schizophrenia 1 (DISC1), and important neuronal enzymes such as PDE4 and GSK3-beta. After completing her PhD, she moved to the USA and spent seven years at Yale University's Department of Molecular Psychiatry, where she worked on a range of projects involving mass-spectrometry proteomic assays across multiple human brain regions. She established an aged rhesus macaque model to study early Alzheimer's Disease and developed cell-type specific techniques for measuring protein translation rates. In 2017, she joined Massachusetts General Hospital and Harvard Medical School's Neurology department, applying proteomic techniques to identify novel tissue and biofluid markers related to Alzheimer's Disease and associated disorders. Upon returning to the UK, she was awarded a Senior Research Fellowship from Alzheimer's Research UK to launch her own research program in autumn 2022.
Department of Politics and International Relations - Higher Level English requirement.